Health-Related Quality of Life With Odronextamab Monotherapy ( CD20 x CD3 bispecific monoclonal antibody) for Relapsed/Refractory Follicular #Lymphoma in the ELM-2 Study

Health-Related Quality of Life With Odronextamab Monotherapy for Relapsed/Refractory Follicular Lymphoma in the ELM-2 Study - PubMed
In this heavily pretreated, highly refractory population, maintenance or improvement of health-related quality of life, functioning, and symptoms support odronextamab as a potential treatment option in R/R FL.